Literature DB >> 15539717

The prevalence of gastroesophageal reflux disease in adult asthmatics.

Toni O Kiljander1, Jukka O Laitinen.   

Abstract

BACKGROUND: Asthma and gastroesophageal reflux disease (GERD) often coexist. However, the results of the studies investigating the prevalence of GERD among patients with asthma vary greatly. STUDY
OBJECTIVE: To investigate the prevalence of GERD in adult patients with asthma. SUBJECTS AND METHODS: The basic study population consisted of 2,225 asthmatic patients who were treated in six specialist-headed hospitals during 1 year. From the common computer-based discharge register, every 14th patient was randomly selected for the study. Ninety of the 149 contacted patients (60%) agreed to participate in the study. Twenty-four-hour esophageal pH monitoring was performed on all patients.
RESULTS: GERD was found in 32 of the patients (36%). Eight of these patients (25%) were free from classical reflux symptoms. Forty-seven of the 90 patients (52%) presented with typical reflux symptoms. Twenty-four of these patients (51%) were found to have abnormal acidic reflux.
CONCLUSIONS: According to the current study, one third of adult patients with asthma have GERD. These patients often do not have typical reflux symptoms. However, the presence of typical reflux symptoms in an asthmatic patient does not seem to guarantee the presence of abnormal acidic reflux.

Entities:  

Mesh:

Year:  2004        PMID: 15539717     DOI: 10.1378/chest.126.5.1490

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  26 in total

1.  Efficacy of esomeprazole for treatment of poorly controlled asthma.

Authors:  John G Mastronarde; Nicholas R Anthonisen; Mario Castro; Janet T Holbrook; Frank T Leone; W Gerald Teague; Robert A Wise
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

2.  Airway reflux, cough and respiratory disease.

Authors:  Ian D Molyneux; Alyn H Morice
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

3.  Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity.

Authors:  Emily DiMango; Janet T Holbrook; Erin Simpson; Joan Reibman; Joel Richter; Surinder Narula; Nancy Prusakowski; John G Mastronarde; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2009-08-06       Impact factor: 21.405

4.  Insight Into the Relationship Between Gastroesophageal Reflux Disease and Asthma.

Authors:  Fehmi Ates; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-11

5.  24-hour esophageal pH-monitoring in children suspected of gastroesophageal reflux disease: analysis of intraesophageal pH monitoring values recorded in distal and proximal channel at diagnosis.

Authors:  Janusz Semeniuk; Maciej Kaczmarski
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

6.  Prevalence of gastro-oesophageal reflux disease symptoms and reflux-associated respiratory symptoms in asthma.

Authors:  Lakmali D Amarasiri; Arunasalam Pathmeswaran; H Janaka de Silva; Channa D Ranasinha
Journal:  BMC Pulm Med       Date:  2010-09-15       Impact factor: 3.317

7.  Asthma and gastroesophageal reflux: End of the blame game.

Authors:  Sachin Kumar; Dheeraj Gupta
Journal:  Lung India       Date:  2009-10

8.  Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome.

Authors:  Liying Yang; Xiaohua Lu; Carlos W Nossa; Fritz Francois; Richard M Peek; Zhiheng Pei
Journal:  Gastroenterology       Date:  2009-04-23       Impact factor: 22.682

9.  Asthma is inversely associated with Helicobacter pylori status in an urban population.

Authors:  Joan Reibman; Michael Marmor; Joshua Filner; Maria-Elena Fernandez-Beros; Linda Rogers; Guillermo I Perez-Perez; Martin J Blaser
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240

10.  Pulmonary manifestations of gastroesophageal reflux disease.

Authors:  Gajanan S Gaude
Journal:  Ann Thorac Med       Date:  2009-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.